← Leaderboards
Mitra Dutta
University Of Illinois At Chicago
$1,897,217
Attributed
$1,897,217
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $358.7K · FY2012–19$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,897,217 · 3
By mechanism
N01$1,860,717 · 2
N02$36,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Asrar B. Malik$58,182,625
- You-Yang Zhao$24,398,532
- Chinnaswamy Tiruppathi$17,495,963
- Richard D Minshall$14,002,730
- Dolly Mehta$25,727,046
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsThrombosisVascular DiseasesPharmaceutical PreparationsProgramsPulmonary HypertensionProduct DevelopmentBaseAdverse EventLifeCoronary ArteriosclerosisAreaDiagnosticDissectionAortic AneurysmAdverse EffectsAdult Respiratory Distress SyndromeHemorrhageCause Of DeathInhibitor/AntagonistInnovationInterestIntracranial ArteryGenerations
Grant awards (7)
IGF::OT::IGF NOVEL DRUG-BASED THERAPY FOR TREATMENT OF VASCULAR LEAKAGE$306,746
N01 · FY2019 · HL · contact PI
NOVEL DRUG-BASED THERAPY FOR TREATMENT OF VASCULAR LEAKAGE, VITA 2$299,165
N01 · FY2018 · HL · contact PI
IGF::OT::IGF NOVEL DRUG-BASED THERAPY FOR TREATMENT OF VASCULAR LEAKAGE$322,865
N01 · FY2017 · HL · contact PI
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): SELECTIVE INHIBITORS OF INTERGIN OUTSIDE-IN SIGNALING AS A NEW GENERATION OF ANTI-THROMBOTICS$296,763
N01 · FY2016 · HL · contact PI
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): SELECTIVE INHIBITORS OF INTERGIN OUTSIDE-IN SIGNALING AS A NEW GENERATION OF ANTI-THROMBOTICS$276,476
N01 · FY2015 · HL · contact PI
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): SELECTIVE INHIBITORS OF INTERGIN OUTSIDE-IN SIGNALING AS A NEW GENERATION OF ANTI-THROMBOTICS$358,702
N01 · FY2014 · HL · contact PI
NCI PERSPCS AND SNEPCS DATA ANALYTIC AND PUBLICATION ACTIVITIES$36,500
N02 · FY2012 · CA · contact PI